Department of Cardiology, Copenhagen University Hospital, Gentofte, Hellerup, Denmark.
Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):428-34. doi: 10.1002/pds.3227. Epub 2012 Feb 17.
Nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with severe renal complications, including acute renal failure, reduced glomerular filtration rate and interstitial nephritis. Caution against NSAIDs is therefore recommended in advanced chronic kidney disease. In this study, we examined NSAID use, aetiology and comorbidity among a national cohort of patients before the initiation of chronic renal replacement therapy (RRT).
Patients initiated on chronic RRT in the period 1997-2006 were identified in the Danish National Registry on Regular Dialysis and Transplantation, including etiological diagnosis. The use of NSAID before the start of RRT was studied by linkage to the National Prescription Register and comorbidity by linkage to the National Patient Registry.
A total of 6663 patients were included in the study, and 2407 patients (36.1%) were prescribed NSAID in the 3 years before the start of RRT. These patients were older (mean age = 63.0 vs 61.4 years) and had a significantly higher degree of comorbidity (Charlson score = 2.85 vs 2.61, p < 0.05) compared with patients not treated with NSAIDs. In the 3 years leading up to RRT, the number of patients treated with NSAID each year and the cumulated median length of treatment including all NSAIDs were stable at approximately 20% and 40 days, respectively.
In this study of a nationwide group of patients, we observed a widespread use of NSAID with an unaffected high annual incidence in the 3 years leading up to the initiation of RRT.
非甾体抗炎药(NSAIDs)可能与严重的肾脏并发症有关,包括急性肾衰竭、肾小球滤过率降低和间质性肾炎。因此,在晚期慢性肾脏病中应谨慎使用 NSAIDs。在这项研究中,我们检查了在开始慢性肾脏替代治疗(RRT)之前,全国范围内一组患者的 NSAID 使用情况、病因和合并症。
在丹麦国家常规透析和移植登记处确定了在 1997 年至 2006 年期间开始接受慢性 RRT 的患者,并包括病因诊断。通过与国家处方登记处的链接研究 RRT 开始前 NSAID 的使用情况,并通过与国家患者登记处的链接研究合并症。
共有 6663 名患者纳入本研究,其中 2407 名患者(36.1%)在开始 RRT 前 3 年内服用 NSAID。这些患者年龄较大(平均年龄=63.0 岁 vs. 61.4 岁),且合并症的严重程度明显更高(Charlson 评分=2.85 vs. 2.61,p<0.05)。在开始 RRT 的 3 年内,每年接受 NSAID 治疗的患者数量以及包括所有 NSAID 的累积中位数治疗时间分别稳定在约 20%和 40 天。
在这项针对全国范围内一组患者的研究中,我们观察到 NSAID 的广泛使用,在开始 RRT 前的 3 年内,其每年的发病率仍然很高。